目的 分析張家口市第一醫(yī)院口服中成藥使用情況,為臨床合理用藥提供參考。方法 從HIS中調(diào)取2019-2021年醫(yī)院口服中成藥的使用數(shù)據(jù),采用Excel統(tǒng)計(jì)用藥品種、用量、銷(xiāo)售金額、計(jì)算其年增長(zhǎng)率、用藥頻度(DDDs)和日均費(fèi)用(DDC)。結(jié)果 2019-2021年,中成藥處方量逐年增加,年增長(zhǎng)率在10%左右;以不同類(lèi)別口服中成藥銷(xiāo)售金額排序,祛瘀劑、扶正劑、清熱劑、祛濕劑連續(xù)3年排在前4位;以DDDs排序,復(fù)方丹參滴丸、腦心通膠囊和銀杏葉滴丸連續(xù)3年排序在前3位;以DDC排序,安宮牛黃丸連續(xù)3年排在首位。結(jié)論 醫(yī)院口服中成藥使用基本合理,但部分品種DDC較高,患者經(jīng)濟(jì)負(fù)擔(dān)較大,須進(jìn)一步加強(qiáng)管理。

Objective To analyze the use of oral Chinese patent medicines in First Hospital of Zhangjiakou City, and to provide reference for clinical rational drug use.Methods The service data of oral Chinese patent medicines in the hospital from 2019 to 2021 were retrieved from HIS, and Excel was used to count the drug variety, dosage, sales amount, and calculate its annual growth rate, DDDs, and DDC.Results From 2019 to 2021, the number of prescriptions of proprietary Chinese medicines increased year by year, with an annual growth rate of about 10%. In order of the sales amount of different types of oral proprietary Chinese medicines, stasisremoving agents, strengthening agents, heat-clearing agents, and damp-removing agents ranked top 4 for 3 consecutive years. In order of DDDs, Compound Danshen Dripping Pills, Naoxintong Capsules and Yinxingye Dropping Pills ranked the top 3 for 3 consecutive years. In terms of DDC, Angong Niuhuang Pills ranked top 1 for 3 consecutive years.Conclusion The use of oral Chinese patent medicines in the hospital is basically reasonable, but some varieties have higher DDC, and the economic burden of patients is relatively large, which needs to be further strengthened.

R288.6

河北省中醫(yī)藥管理局科研計(jì)劃項(xiàng)目(2019536)